Robert Califf

Business address
Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco, CA, 94080
Top holdings (ownership)
CYTK
Get insider transactions for this reporting owner
Robert Califf has filed 20 SEC EDGAR filings since 21 May 2013

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 04 Jan 2022 03 Jan 2022 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 04 Oct 2021 01 Oct 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 08 Jul 2021 07 Jul 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jul 2021 01 Jul 2021 000-50633
3 Open Document Open Filing FORM 3 SUBMISSION 27 May 2021 27 May 2021 001-40445
4 Open Document Open Filing PRIMARY DOCUMENT 13 May 2021 12 May 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 05 Apr 2021 01 Apr 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 05 Jan 2021 04 Jan 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 14 May 2020 13 May 2020 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 14 Feb 2020 12 Feb 2020 000-50633
4/A Open Document Open Filing PRIMARY DOCUMENT 29 Jan 2020 02 Jan 2020 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 06 Jan 2020 02 Jan 2020 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 17 May 2019 15 May 2019 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 04 Jan 2019 02 Jan 2019 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 17 May 2018 16 May 2018 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT 12 Feb 2018 08 Feb 2018 000-50633
3 Open Document Open Filing PRIMARY DOCUMENT 12 Feb 2018 08 Feb 2018 000-50633
4 Open Document Open Filing FORM 4 SUBMISSION 01 Jul 2014 27 Jun 2014 001-35935